Jianlong Sheng

434 citations
10 papers · 264 indexed · h-index 5
Topics
Inflammatory Biomarkers in Disease Prognosis (2 papers)Antiplatelet Therapy and Cardiovascular Diseases (2 papers)Atrial Fibrillation Management and Outcomes (2 papers)
Partner nations
China

In The Last Decade

Jianlong Sheng

9 papers receiving 260 citations

Peers

Jianlong Sheng
Comparison fields: 5 of 71
  • Molecular Biology 147
  • Nephrology 51
  • Cardiology and Cardiovascular Medicine 48
  • Pathology and Forensic Medicine 41
  • Surgery 35
Replace Marwa Mohamed Atef with:
Marwa Mohamed Atef Egypt
Nan Mao China
Chun Tang China
Victoria Bocanegra Argentina
Qianwei Cui China
Yunyun Zhao China
Hongwei Ye China
Weiyan Lai China
Jianlong Sheng relative to Marwa Mohamed Atef Egypt Marwa Mohamed Atef's profile →
Citations per field
00.5×1.6×
Marwa Mohamed Atef · 1×
Citations per year

Countries citing papers authored by Jianlong Sheng

Since Specialization
Citations

This map shows the geographic impact of Jianlong Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianlong Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianlong Sheng more than expected).

Fields of papers citing papers by Jianlong Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianlong Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianlong Sheng. The network helps show where Jianlong Sheng may publish in the future.

Co-authorship network of co-authors of Jianlong Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jianlong Sheng. A scholar is included among the top collaborators of Jianlong Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianlong Sheng. Jianlong Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 3
2 4
3 3
4 15
5 150
6 0
7 2
8 6
9 25
10 56

About Jianlong Sheng

Jianlong Sheng is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Complementary and alternative medicine, having authored 10 papers that have together received 264 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Nephrology (51 citations), Pathology and Forensic Medicine (41 citations) and Molecular Biology (147 citations). Jianlong Sheng has collaborated with scholars based in China. Frequent co-authors include Fei He, Banglong Xu, Cheng Cheng, Nina Liu, Youmin Wang, Tianrong Pan, Xiaochen Wang, Cai Chen, Yuting Sun and Jian Xu. Their work appears in journals such as Journal of the American College of Cardiology, Biomedicine & Pharmacotherapy and Evidence-based Complementary and Alternative Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026